4Y4.F BIO-UV GROUP SAS EO1
- Market cap
- -
- P/E
- -
- P/B
- 0.25x
- ROE
- 2.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 4Y4.F undervalued?
Graham numberThe Graham number of BIO-UV GROUP SAS EO1 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
BIO-UV GROUP SAS EO1 fundamental analysis
No fundamental analysis for BIO-UV GROUP SAS EO1 yet.
BIO-UV GROUP SAS EO1 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
BIO-UV GROUP SAS EO1 financial statements
BIO-UV GROUP SAS EO1 annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 33.5M | 51.3M | 43.1M | 39.6M | 35.9M |
| Gross Profit | 11.9M | 28.2M | 25.6M | 24.1M | 23.9M |
| Operating Income | 1.03M | 4.15M | 2.31M | 2.13M | 1.56M |
| EBITDA | - | 6.90M | 4.43M | 4.18M | 4.45M |
| Net Income | 689K | 2.42M | 125K | 31.4K | 836K |
| EPS | 0.07 | 0.24 | 0.01 | 0.00 | 0.06 |
| Balance Sheet | |||||
| Total Assets | 81.1M | 74.1M | 71.4M | 66.1M | 69.2M |
| Total Liabilities | 50.5M | 41.7M | 39.2M | 33.4M | 28.7M |
| Shareholders' Equity | 30.7M | 32.4M | 32.2M | 32.7M | 40.5M |
| Cash & Short-term Investments | 10.2M | 1.98M | 2.73M | 3.87M | 8.68M |
| Cash Flow | |||||
| Operating Cash Flow | 3.30M | 2.70M | 6.24M | 6.90M | 4.63M |
| Capital Expenditure | 2.73M | 2.22M | 1.96M | 1.94M | 1.64M |
| Free Cash Flow | 572K | 476K | 4.28M | 4.96M | 2.99M |
| Ratios | |||||
| ROE | 2.2% | 7.5% | 0.4% | 0.1% | 2.1% |
| ROA | 0.8% | 3.3% | 0.2% | 0.0% | 1.2% |
| Net Profit Margin | 2.1% | 4.7% | 0.3% | 0.1% | 2.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
BIO-UV GROUP SAS EO1 dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | EUR 607K | 0.06 | 486.1% |
| 2022 | EUR 505K | 0.05 | 20.9% |
| 2021 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns BIO-UV GROUP SAS EO1
Ownership data of BIO-UV GROUP SAS EO1 is not available yet.
BIO-UV GROUP SAS EO1 company profile
- Company name
- BIO-UV GROUP SAS EO1
- Ticker
- 4Y4.F
- ISIN
- FR0013345493
- Exchange
- Frankfurt Exchange
- Sector
- -
- Industry
- -
- Fiscal year end
- December
- Address
- Website
- -